Zylox-Tonbridge Medical Technology Co., Ltd.
Zylox-Tonbridge Medical Technology Co., Ltd. (HKSE: 2190) is trading at HK$21.60, about ₹265 at today's HKD/INR rate, as of 25 Sep 2026, 4:08 AM ET, up 1.41% today. Indian residents can buy Zylox-Tonbridge Medical Technology from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$20.74
Today's high
HK$21.60
52 week low
HK$17.10
52 week high
HK$28.00
2190 opened at HK$21.32, closed previously at HK$21.30, and has traded between HK$17.10 and HK$28.00 over the past 52 weeks.
About
Zylox-Tonbridge Medical Technology Co., Ltd. is a global medical device firm specializing in neurovascular and peripheral vascular interventional technologies. Their comprehensive product line for treating ischemic stroke includes the ThromBite Clot Retriever, designed to extract clots from major brain vessels, as well as aspiration and balloon guiding catheters. For peripheral vascular conditions, they offer the ZENFLEX Pro Drug-eluting Stent System for managing complex and recurring symptomatic lesions, the self-expanding ZENFlex Peripheral Stent System for deployment in the iliac, superficial femoral, and proximal popliteal arteries, and drug-coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters for treating arterial stenoses or blockages in these same regions. Their neurovascular offerings further extend to Ton-Bridge extra soft coils, utilized for the endovascular embolization of intracranial aneurysms and other cerebral vascular malformations like arteriovenous malformations (AVMs) and fistulae. Supporting these are a range of microcatheters (for coiling or selective agent delivery), distal access and intracranial PTA balloon catheters, vascular snares, and IVC filter snare retrieval kits. Established in 2012, Zylox-Tonbridge Medical Technology Co., Ltd. maintains its headquarters in Zhejiang, People's Republic of China.
Key statistics
Avg. volume
552.26K
Market cap
HK$6.71B
P/E Ratio
19.45
Price-to-sales ratio
4.75
Enterprise value
CN¥5.30B
Free cash flow yield
2.98%
Debt-to-equity ratio
0.05
Return on equity
9.72%
ROIC
8.08%
Beta
0.31
Dividend yield
1.67%
Last dividend
HK$0.36
Financial overview
Revenue
CN¥1.06B
Earnings per share
CN¥0.76
Free cash flow
CN¥268.72M
Net profit margin
25.08%
Gross margin
73.18%
EBITDA
CN¥231.92M
Revenue growth
35.15%
Similar securities
This is not an investment recommendation
How to buy Zylox-Tonbridge Medical Technology from India
Indian residents can buy Zylox-Tonbridge Medical Technology shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for Zylox-Tonbridge Medical Technology and place an order
Find Zylox-Tonbridge Medical Technology by name or by its ticker, 2190, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. Zylox-Tonbridge Medical Technology trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Zylox-Tonbridge Medical Technology position in HKD and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in Zylox-Tonbridge Medical Technology from India
Trading and taxes when buying Zylox-Tonbridge Medical Technology from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Zylox-Tonbridge Medical Technology’s current yield is 1.67%.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Zylox-Tonbridge Medical Technology stock?
Yes. Zylox-Tonbridge Medical Technology (2190) has been listed on the Hong Kong Stock Exchange since 2021, in the Medical - Devices industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Zylox-Tonbridge Medical Technology share cost in rupees?
One Zylox-Tonbridge Medical Technology share is HK$21.60 — about ₹265 at an HKD/INR rate of 12.25 on 24 Sep 2026. Both the Zylox-Tonbridge Medical Technology price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Zylox-Tonbridge Medical Technology from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Zylox-Tonbridge Medical Technology?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on Zylox-Tonbridge Medical Technology shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Zylox-Tonbridge Medical Technology price. Paasa issues a capital-gains statement for your return.
Does Zylox-Tonbridge Medical Technology pay a dividend, and how is it taxed in India?
Yes. Zylox-Tonbridge Medical Technology pays a dividend and the current yield is 1.67%; the last declared dividend was HK$0.36 per share, about ₹4.42. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade Zylox-Tonbridge Medical Technology from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is Zylox-Tonbridge Medical Technology a Hong Kong SAR China company, and does that change how it is taxed?
Zylox-Tonbridge Medical Technology trades on the Hong Kong Stock Exchange in HKD, but the company is domiciled in China. Zylox-Tonbridge Medical Technology trades as an ordinary share listed directly in Hong Kong, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare Zylox-Tonbridge Medical Technology shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Zylox-Tonbridge Medical Technology holding, its cost and its closing value.
How do I sell Zylox-Tonbridge Medical Technology and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.